Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

AstraZeneca initiates phase I trial of AZD-0284 for plaque psoriasis

Dec. 29, 2016

Bristol-Myers Squibb initiates phase II trial of BMS-986165

Dec. 29, 2016

Neothetics initiates phase II trial of LIPO-202 for the reduction of submental subcutaneous fat

Dec. 27, 2016

Allergan to acquire LifeCell

Dec. 21, 2016

Novartis to acquire Ziarco

Dec. 16, 2016

FDA approves Eucrisa for atopic dermatitis

Dec. 15, 2016

Concert Pharmaceuticals completes phase I study of JAK inhibitor for alopecia areata

Dec. 15, 2016

Almirall and Nuevolution to jointly develop RORgammat inhibitors

Dec. 13, 2016

Purdue Pharma and Exicure enter collaboration agreement in psoriasis

Dec. 13, 2016

Valeant Pharmaceuticals reports positive results from phase III study of IDP-118

Dec. 12, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...